Cargando…
Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
HIV infection still remains a major challenge for healthcare systems of the world. There are several aspects on counteracting the HIV/AIDS epidemic. The f irst aspect covers preventive measures including educational campaigns on HIV/AIDS and promotion of a healthy lifestyle, protected sex, and pre-e...
Autores principales: | Rudometova, N.B., Shcherbakov, D.N., Rudometov, A.P., Ilyichev, A.A., Karpenko, L.I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983303/ https://www.ncbi.nlm.nih.gov/pubmed/35434492 http://dx.doi.org/10.18699/VJGB-22-26 |
Ejemplares similares
-
The Structural and Immunological Properties of Chimeric Proteins Containing HIV-1 MPER Sites
por: Rudometov, A. P., et al.
Publicado: (2019) -
Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope
por: Rudometov, Andrey P., et al.
Publicado: (2019) -
Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
por: Shcherbakov, D. N., et al.
Publicado: (2015) -
Phage display as a tool for identifying
HIV-1 broadly neutralizing antibodies
por: Chikaev, A.N., et al.
Publicado: (2021) -
P19-13. Recombinant proteins carrying peptide mimics of HIV-1
por: Chikaev, A, et al.
Publicado: (2009)